PFG Investments LLC Sells 1,840 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

PFG Investments LLC cut its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 21.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,726 shares of the exchange traded fund’s stock after selling 1,840 shares during the period. PFG Investments LLC’s holdings in SPDR S&P Biotech ETF were worth $601,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. JPMorgan Chase & Co. lifted its position in shares of SPDR S&P Biotech ETF by 179.1% during the first quarter. JPMorgan Chase & Co. now owns 7,534,471 shares of the exchange traded fund’s stock worth $574,202,000 after purchasing an additional 4,835,071 shares in the last quarter. Jane Street Group LLC boosted its position in SPDR S&P Biotech ETF by 111.4% in the 2nd quarter. Jane Street Group LLC now owns 172,730 shares of the exchange traded fund’s stock valued at $12,829,000 after buying an additional 1,682,382 shares during the last quarter. Migdal Insurance & Financial Holdings Ltd. bought a new position in SPDR S&P Biotech ETF in the 3rd quarter valued at $102,900,000. Healthcare of Ontario Pension Plan Trust Fund increased its stake in shares of SPDR S&P Biotech ETF by 103.3% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 1,771,000 shares of the exchange traded fund’s stock valued at $129,318,000 after buying an additional 900,000 shares during the period. Finally, Squarepoint Ops LLC bought a new stake in shares of SPDR S&P Biotech ETF during the first quarter worth $34,666,000.

SPDR S&P Biotech ETF Stock Up 2.4 %

SPDR S&P Biotech ETF stock opened at $94.91 on Thursday. The business’s 50-day simple moving average is $93.27 and its 200 day simple moving average is $82.57. The stock has a market cap of $7.28 billion, a price-to-earnings ratio of 11.47 and a beta of 0.97. SPDR S&P Biotech ETF has a 12-month low of $63.80 and a 12-month high of $103.52.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.